
Pretreatment Plasma sCD14 Predicts Lung Cancer Immunotherapy Outcomes
In the evolving landscape of cancer treatment, immunotherapy has emerged as a revolutionary approach, particularly for patients with advanced non-small cell lung cancer (aNSCLC). Despite significant progress, predicting which patients will benefit …